Abstract:Objective To prove that holmium laser prostatectomy (HoLEP) is safe and effective in the treatment of benign prostatic hyperplasia (BPH), and is superior to transurethral prostatectomy (TURP) for elderly patients. Methods We retrospectively studied 565 HoLEP patients and 76 TURP elderly patients. HoLEP patients were first divided into three groups according to their age(Under 65 years old group, 65–79 years old group and over 80 years old group), and their preoperative, intraoperative, and postoperative characteristics were then compared. Secondly, the same characteristics of HoLEP and TURP patients over 80 years were compared. Chi-square test, one-way ANOVA and Fisher's exact test were used in this study. Results Firstly, we compared HoLEP patients in different age groups and found that there was statistically significant difference in diabetes, CCVD and bladder stones, among the three groups (P<0.05). Secondlye, we compared HoLEP and TURP treatments in elderly patients (≥80 years old). The patients with HoLEP had a higher share of diabetes, CCVD and anticoagulation (P<0.05). Moreover, compared with TURP patients, HoLEP patients had shorter enucleation duration, more enucleate prostate weight, fewer hemoglobin diminutions, shorter bladder irrigation time, shorter catheter-indwelling period, and shorter hospital period (P 0.05), the difference was statistically significant, 6 months after the operation (P<0.05). Conclusion HoLEP is safe and effective for BPH patients, and is superior to transurethral TURP for elderly patients. Zielsetzung Es sollte nachgewiesen werden, dass die Holmium-Laser-Prostatektomie (HoLEP) bei der Behandlung der benignen Prostatahyperplasie (BPH) sicher und wirksam ist und der transurethralen Prostatektomie (TURP) bei älteren Patienten überlegen ist. Methoden Wir haben retrospektiv 565 HoLEP-Patienten und 76 ältere TURP-Patienten untersucht. Die HoLEP-Patienten wurden zunächst nach ihrem Alter in drei Gruppen eingeteilt (die Gruppe der unter 65-Jährigen, die Gruppe der 65–79-Jährigen und die Gruppe der über 80-Jährigen), und dann wurden ihre präoperativen, intraoperativen und postoperativen Merkmale verglichen. Zweitens wurden die gleichen Merkmale von HoLEP- und TURP-Patienten über 80 Jahren verglichen. In dieser Studie wurden der Chi-Quadrat-Test, die einseitige ANOVA und der exakte Test von Fisher verwendet. Ergebnisse Erstens verglichen wir HoLEP-Patienten in verschiedenen Altersgruppen und stellten fest, dass es einen statistisch signifikanten Unterschied bei Diabetes, CCVD und Blasensteinen zwischen den 3 Gruppen gab (P<0,05). Zweitens verglichen wir HoLEP- und TURP-Behandlungen bei älteren Patienten (≥80 Jahre alt). Die Patienten mit HoLEP hatten einen höheren Anteil an Diabetes, CCVD und Antikoagulation (P<0,05). Außerdem hatten HoLEP-Patienten im Vergleich zu TURP-Patienten eine kürzere Enukleationsdauer, ein höheres Gewicht der enukleierten Prostata, eine geringere Hämoglobinverminderung, eine kürzere Blasenspülungszeit, eine kürzere Katheterverweildauer und einen kürzeren Krankenhausaufenthalt (P 0,05), war der Unterschied 6 Monate nach der Operation statistisch signifikant (P<0,05). Schlussfolgerung Die HoLEP ist bei BPH-Patienten sicher und wirksam und der transurethralen TURP bei älteren Patienten überlegen. Received: 08 September 2023 Accepted after revision: 02 November 2023 Article published online: 23 January 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Functional Outcome and Safety of Endoscopic Treatment Options for Benign Prostatic Obstruction (BPO) in Patients ≥ 75 Years of Age

Holmium Laser Enucleation of the Prostate is Safe for Patients Above 80 Years: A Prospective Study

Safety and Efficacy of Laser Enucleation of the Prostate in Elderly Patients - A Narrative Review

Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study

Evaluation of the effectiveness and safety of laser enucleation of the prostate in different age groups.

The impact of preoperative lower urinary tract symptoms medication on the functional performance of holmium laser enucleation of the prostate

Functional and safety outcomes after benign prostatic enlargement surgeries in men with detrusor underactivity compared with normal detrusor contractility: Systematic review and meta-analysis

Comparison of Clinical Therapeutic Efficacy between TUPKP and HoLEP for Patients Aged 70 Years and Older with Benign Prostatic Hyperplasia: Retrospective Study

Holmium laser enucleation of the prostate: A truly size‐independent method?

Pharmacological and interventional treatment of benign prostatic obstruction: An evidence-based comparative review

Benefits and Harms of Benign Prostatic Obstruction Treatments in Renal Transplanted Patients

Endourological treatment for benign prostate hyperplasia in elderly high-risk patients

Sectionalized transurethral plasmakinetic resection of prostate in treatment of advanced age patients ;with benign prostatic hyperplasia

Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review

[Management of geriatric patients with benign prostatic hyperplasia]

Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis

Clinical Observation of Transurethral Bipolar Plasmakinetic Resection of Prostate for Benign Prostatic Hyperplasia in Super-Aged Men

Comparison of the efficacy of HoLEP and TURP in the treatment of elderly benign prostatic hyperplasia patients: a retrospective study

Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial

Perioperative Parameters and Prognosis Analysis of Patients Aged 80 Years Old or Older Treated with Radical Prostatectomy for Prostate Cancer

Evaluation of Current Surgical BPH Interventions for Young and Elderly Men